MedICAL ADVOCATES
Children
  Opportunistic Diseases
 
Guidelines
General Reports
 OI Drugs: General
Aspergillosis 
 Candidiasis              
Coccidioidomycosis
 Cryptococcosis
Cryptosporidiosis
CMV
Histoplasmosis
 		 Kaposi's Sarcoma
Microsporidiosis
 M. avium complex 
 Penicilliosis  
PCP
 Toxoplasmosis 




 





 
Pediatric Disease Index Main New/Newsworthy  Home Page
Last Update:  December 02, 2015      
  Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Prevention/Treatment Guidelines
       

     Journal Papers, Abstracts, and Commentaries     

 
Executive Summary: Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations From the National Institutes of Health, the Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
 Siberry GK, Abzug MJ, Nachman S; Panel on Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children—a working group of the Office of AIDS Research (OAR) Advisory Council*.
  J Pediatric Infect Dis Soc. 2013 Dec;2(4):293-308
 Abstract

FULL-TEXT PDF ARTICLE
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health,
the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
Mofenson LM, Brady MT, Danner SP,et al
MMWR Recomm Rep. 2009 Sep 4;58(RR-11):1-166
 Paper

FULL-TEXT ARTICLE
Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
Mofenson LM, Oleske J, Serchuck L, et al
MMWR Dec 3, 2004 / 53(RR14);1-63
 Paper

  
General Reports
       

          Journal Papers, Abstracts, and Commentaries     

 
Incidence, risk factors, and outcomes of opportunistic infections in pediatric renal transplant recipients.
Jordan CL, Taber DJ, Kyle MO, Connelly J,  et al
Pediatr Transplant. 2015 Nov 18
 Abstract

Impact of Antiretroviral Therapy on Opportunistic Infections of HIV-Infected Children in the TREAT Asia Pediatric HIV Observational Database.
Prasitsuebsai W, Kariminia A, Puthanakit T,  et al
Pediatr Infect Dis J. 2013 Dec 30
 Abstract
 

Incidence of Opportunistic Illness Before and After Initiation of Highly Active Antiretroviral Therapy in Children
Nesheim SR, Hardnett F, Wheeling JT,  
 Pediatr Infect Dis J. 2013 Oct;32(10):1089-1095.
 Abstract

Trends in Opportunistic Infections in the Pre-and Post-Highly Active Antiretroviral Therapy Eras Among HIV-Infected Children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
 Nesheim SR, Kapogiannis BG, Soe MM, et al 
Pediatrics. 2007 Jul;120(1):100-9
 Abstract

Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Ylitalo N, Brogly S, Hughes MD, Nachman S, et al 
Arch Pediatr Adolesc Med. 2006 Aug;160(8):778-87.
Abstract
 
Incidence of opportunistic and other infections in HIV-infected children in the HAART era.
Gona P, Van Dyke RB, Williams PL, et al; J
AMA. 2006 Jul 19;296(3):292-300.
Abstract
 
The Rate of Serious Bacterial Infections Among HIV-Infected Children With Immune Reconstitution Who Have Discontinued Opportunistic Infection Prophylaxis.
Nachman S, Gona P, Dankner W, et al 
Pediatrics. 2005 Mar 16;
Abstract

Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy.
Dankner WM, Lindsey JC, Levin MJ;
Pediatr Infect Dis J 2001 Jan;20(1):40-8
Abstract
 

  

           Conference Reports, Abstracts, and Posters 

  Incidence of opportunistic infections (OIs): pneumocystis carinii (PCP), candidiasis, cryptococcus, cryptosporidium, toxoplasmosis, Kaposi's sarcoma, herpes simplex (HSV), varicella-zoster (VZV) and cytomegalovirus (CMV) in HIV-infected children in resour
M.-R. B-Lajoie, O. Drouin, A. Low. et al
(6th IAS Conference)
 Abstract
OI Drugs: General
       
Caspofungin
 
          Journal Papers, Abstracts, and Commentaries    
 
  Caspofungin: in pediatric patients with fungal infections.
Garnock-Jones KP, Keam SJ.
Paediatr Drugs. 2009;11(4):259-69.
 Abstract

Cotrimoxazole       

          Conference Reports, Abstracts, and Posters 
 
  A Randomized Placebo-controlled Trial of Cotrimoxazole as Prophylaxis against Opportunistic Infections in Children with HIV-1 Infection in Zambia
V Mulenga, D Gibb, G Bhat, et al
 (11 CROI)
 Abstract
 

Trimethoprim-Sulfamethoxazole

          Journal Papers, Abstracts, and Commentaries     

 
Oral trimethoprim-sulphamethoxazole levels in stable HIV-infected children.
Zar HJ, Langdon G, Apolles P, et al
S Afr Med J. 2006 Jul;96(7):627-9.
 Abstract

Trimethoprim-sulfamethoxazole induced prolonged hypoglycemia in an infant with  MHC class II deficiency: diazoxide as a treatment option.
Gonc EN, Turul T, Yordam N, Ersoy F.
J Pediatr Endocrinol Metab. 2003 Dec;16(9):1307-9
Abstract

Pediatric Disease Index Main New/Newsworthy  Home Page

Photo by Caroline Jacoby Courtesy of M/MC Photoshare at www.jhuccp.org/mmc  and is protected by current copyright law 
Pediatric Internet Resource Center
Opportunistic Infections Index